Literature DB >> 1911298

Platelet and coagulation studies in Ehlers-Danlos syndrome.

A Anstey1, K Mayne, M Winter, J Van de Pette, F M Pope.   

Abstract

Fifty-one patients with Ehlers-Danlos syndrome were investigated for abnormalities of platelets and coagulation. Thirty-eight were examined prospectively and 13 retrospectively. A bleeding history was taken from all patients; only four (8%) gave no history of a bruising or bleeding tendency. Nine patients (18%) had significant haemostatic abnormalities of whom four (8%) had a platelet release defect, three (6%) had a factor XI deficiency and two (4%) had a factor XIII deficiency. Additionally 16 patients (31%) had mild abnormalities of uncertain significance of whom four (8%) had prolonged bleeding times (three in association with platelet aggregation abnormalities), 13 (26%) had platelet aggregation abnormalities and two had a positive Hess test. Twenty-four patients (47%) had normal tests for haemostasis of whom 20 (39%) had a bleeding diathesis and four (8%) had no such tendency. Results were analysed according to the type of Ehlers-Danlos syndrome, but there was no pattern to the abnormalities. The high frequency of a bleeding tendency in Ehlers-Danlos patients with normal tests for haemostasis (83%) supports the conventional explanation for this clinical feature, that defects in the structural integrity of skin and blood vessels lead to easy bruising.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1911298     DOI: 10.1111/j.1365-2133.1991.tb06063.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  8 in total

1.  Postural orthostatic tachycardia syndrome (POTS): association with Ehlers-Danlos syndrome and orthopaedic considerations.

Authors:  Emmanouil Grigoriou; Jeffrey R Boris; John P Dormans
Journal:  Clin Orthop Relat Res       Date:  2014-08-26       Impact factor: 4.176

2.  Homozygous factor V Leiden mutation in type IV Ehlers-Danlos patient.

Authors:  Marwan Refaat; Mostafa Hotait; Brion Winston
Journal:  World J Clin Cases       Date:  2014-03-16       Impact factor: 1.337

3.  Epidemiology of bleeding symptoms and hypermobile Ehlers-Danlos syndrome in paediatrics.

Authors:  S E Hickey; E A Varga; B Kerlin
Journal:  Haemophilia       Date:  2016-08-26       Impact factor: 4.287

4.  PREDICTED STRUCTURE AND BINDING MOTIFS OF COLLAGEN α1(XI).

Authors:  Owen M McDougal; Lisa R Warner; Chris Mallory; Julia Thom Oxford
Journal:  GSTF Int J Bioinforma Biotechnol       Date:  2011-12

5.  Vascular type Ehlers-Danlos syndrome is associated with platelet dysfunction and low vitamin D serum concentration.

Authors:  Albert Busch; Sabine Hoffjan; Frauke Bergmann; Birgit Hartung; Helena Jung; Daniela Hanel; Andeas Tzschach; Janos Kadar; Yskert von Kodolitsch; Christoph-Thomas Germer; Heiner Trobisch; Erwin Strasser; René Wildenauer
Journal:  Orphanet J Rare Dis       Date:  2016-08-03       Impact factor: 4.123

Review 6.  Ehlers-Danlos Syndrome-Hypermobility Type: A Much Neglected Multisystemic Disorder.

Authors:  Yael Gazit; Giris Jacob; Rodney Grahame
Journal:  Rambam Maimonides Med J       Date:  2016-10-31

7.  Spinal Anaesthesia for Cesarean Section in a Patient with Vascular Type Ehlers-Danlos Syndrome.

Authors:  Jeffrey M Carness; Mark J Lenart
Journal:  Case Rep Anesthesiol       Date:  2018-01-28

Review 8.  Recommendations for anesthesia and perioperative management in patients with Ehlers-Danlos syndrome(s).

Authors:  Thomas Wiesmann; Marco Castori; Fransiska Malfait; Hinnerk Wulf
Journal:  Orphanet J Rare Dis       Date:  2014-07-23       Impact factor: 4.123

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.